FTC sues major pharmacy benefit supervisors about insulin costs The agency brought action towards Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the listing price of lifetime-conserving insulin medicines. Insurers will continue vertically integrating to maintain additional earnings in-property, and federal s... https://jeffreytkarh.blogunteer.com/29892864/the-ultimate-guide-to-healthcare-news